4.8 Article

A Comprehensive DNA Methylation Profile of Epithelial-to-Mesenchymal Transition

期刊

CANCER RESEARCH
卷 74, 期 19, 页码 5608-5619

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-13-3659

关键词

-

类别

资金

  1. European Research Council [268626-EPINORC]
  2. Cellex Foundation
  3. Sandra Ibarra Foundation
  4. Ministry of Economy and Competitiveness [SAF2011-22803]
  5. Generalitat de Catalunya
  6. ICREA Funding Source: Custom

向作者/读者索取更多资源

Epithelial-to-mesenchymal transition (EMT) is a plastic process in which fully differentiated epithelial cells are converted into poorly differentiated, migratory and invasive mesenchymal cells, and it has been related to the metastasis potential of tumors. This is a reversible process and cells can also eventually undergo mesenchymal-to-epithelial transition. The existence of a dynamic EMT process suggests the involvement of epigenetic shifts in the phenotype. Herein, we obtained the DNA methylomes at single-base resolution of Madin-Darby canine kidney cells undergoing EMT and translated the identified differentially methylated regions to human breast cancer cells undergoing a gain of migratory and invasive capabilities associated with the EMT phenotype. We noticed dynamic and reversible changes of DNA methylation, both on promoter sequences and gene-bodies in association with transcription regulation of EMT-related genes. Most importantly, the identified DNA methylation markers of EMT were present in primary mammary tumors in association with the epithelial or the mesenchymal phenotype of the studied breast cancer samples. (C) 2014 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Cancer epigenetics in clinical practice

Veronica Davalos, Manel Esteller

Summary: Cancer development is caused by changes in the structure and function of the genome. Epigenetic alterations regulate gene expression programs that promote tumorigenesis and can be used as useful tools in clinical decision making. Unlike genetic changes, epigenetic modifications can be reversed, making them an attractive target for drug development.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Review Oncology

International consensus on the initial diagnostic workup of cancer of unknown primary

Iris van der Strate, Fatemeh Kazemzadeh, Iris D. Nagtegaal, Debbie Robbrecht, Agnes van de Wouw, Catarina S. Padilla, Saskia Duijts, Manel Esteller, F. Anthony Greco, Nicholas Pavlidis, Amir Qaseem, Petur Snaebjornsson, Sophie Veldhuijzen van Zanten, Caroline Loef

Summary: The study proposes a multi-layer classification for the diagnostic workup of CUP using the Delphi method. The recommended initial diagnostic includes history and physical examination, full blood count, serum marker analysis, biopsy of accessible lesion, CT scan, and immunohistochemical testing. Consensus was also reached on the need for an ideal diagnostic lead time for CUP patients.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023)

Article Biochemistry & Molecular Biology

Global Impairment of Immediate-Early Genes Expression in Rett Syndrome Models and Patients Linked to Myelination Defects

Paolo Petazzi, Olga Caridad Jorge-Torres, Antonio Gomez, Iolanda Scognamiglio, Jordi Serra-Musach, Angelika Merkel, Daniela Grases, Clara Xiol, Mar O'Callaghan, Judith Armstrong, Manel Esteller, Sonia Guil

Summary: Rett syndrome is a severe neurodevelopmental disease caused by mutations in the MeCP2 gene, which affects synaptic plasticity and neuronal activity. The MeCP2 protein is critical for the proper expression of immediate-early genes (IEGs) involved in activity-dependent responses, and abnormal expression of IEGs is found in MeCP2-deficient neurons and in RTT patients. These findings highlight the importance of IEGs in synaptic development and the regulatory role of MeCP2.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Unexpected thermodynamic signature for the interaction of hydroxymethylated DNA with MeCP2

David Ortega-Alarcon, Rafael Claveria-Gimeno, Sonia Vega, Olga C. Jorge-Torres, Manel Esteller, Olga Abian, Adrian Velazquez-Campoy

Summary: Hydroxymethylated cytosine (5hmC) is a stable DNA epigenetic mark that interacts with MeCP2 in a distinct mode with a specific thermodynamic signature. Mutations associated with Rett syndrome alter the interaction between MeCP2 and dsDNA in a cytosine modification-specific manner, which may be correlated with disease onset time and clinical severity score.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

Article Biochemistry & Molecular Biology

Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease

Miriam Gene, Miriam Cuatrecasas, Irene Amat, Jesus Alberto Veiga, Maria Jesus Fernandez Acenero, Victoria Fuste Chimisana, Jordi Tarragona, Ismael Jurado, Rebeca Fernandez-Victoria, Carolina Martinez Ciarpaglini, Cristina Alenda Gonzalez, Carlos Zac, Pilar Ortega de la Obra, Maria Teresa Fernandez-Figueras, Manel Esteller, Eva Musulen

Summary: Colitis-associated colorectal carcinoma (CAC) in inflammatory bowel disease (IBD) is caused by p53 alterations and follows a chronic inflammation-dysplasia-cancer carcinogenesis pathway. Gastric metaplasia (GM) is described as the initial event of serrated colorectal cancer (CRC) in the colon mucosa under chronic stress. This study analyzed p53 alterations and microsatellite instability (MSI) to characterize CAC and investigate its relationship with GM. Results showed that p53 mutation pattern was present in more than half of the CAC cases, with stable (MSS) tumors being the most common and MUC5AC negative. Only six unstable (MSI-H) tumors had wild-type p53 pattern (p=0.010) and were MUC5AC positive (p=0.005). MUC5AC staining was more frequently observed in intestinal mucosa with inflammation or chronic changes than in CAC, particularly in those with wild-type p53 pattern and MSS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Crosstalk between Metabolite Production and Signaling Activity in Breast Cancer

Cankut Cubuk, Carlos Loucera, Maria Pena-Chilet, Joaquin Dopazo

Summary: Reprogramming metabolism is a key feature of cancer, and recent research suggests that metabolites may play a crucial role in regulating signaling pathways. Mechanistic models were used to analyze the metabolic and signaling pathway activities of Breast invasive Carcinoma (BRCA), and Gaussian Processes combined with SHapley Additive exPlanations (SHAP) were employed to identify potential causal relationships between metabolite production and signaling pathway regulation. A total of 317 metabolites were found to significantly impact signaling circuits, revealing a complex crosstalk between signaling and metabolic pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer

Ruben Olivera-Salguero, Elia Segui, Juan Miguel Cejalvo, Mafalda Oliveira, Pablo Tolosa, Maria Vidal, Marcos Malumbres, Joaquin Gavila, Cristina Saura, Sonia Pernas, Rafael Lopez, Mireia Margeli, Judith Balmana, Montserrat Munoz, Isabel Blancas, Valentina Boni, Eva Ciruelos, Elena Galve, Antonia Perello, Rodrigo Sanchez-Bayona, Susana de la Cruz, Miguel de la Hoya, Patricia Galvan, Esther Sanfeliu, Blanca Gonzalez-Farre, Valeria Sirenko, Aura Blanch-Torras, Jordi Canes, Helena Masanas, Rosa Olmos, Margarita Forns, Aleix Prat, Ana Casas, Tomas Pascual

Summary: This study aims to promote active patient participation in the management of metastatic breast cancer (mBC) through a digital tool, providing NGS testing and medical interpretation and recommendations from a multidisciplinary molecular advisory board (MAB), to overcome the challenges of limited access and high cost of NGS in clinical practice.

FRONTIERS IN ONCOLOGY (2023)

Article Cell Biology

MYC activation impairs cell-intrinsic IFNy signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer

Juan J. Alburquerque-Bejar, Pablo Navajas-Chocarro, Maria Saigi, Ana Ferrero-Andres, Juan M. Morillas, Andrea Vilarrubi, Antonio Gomez, JoseL. Mate, Ana M. Munoz-Marmol, Octavio A. Romero, Pedro Blecua, Veronica Davalos, Manel Esteller, Eva Pros, Paula Llabata, Manuel Torres-Diz, Anna Esteve-Codina, Montse Sanchez-Cespedes

Summary: This study reveals subsets of lung cancer that are completely refractory or show submaximal response to interferon-γ (IFNy) stimulation, which may be due to JAK2 or IFNGR1 inactivation and impaired IFNy-stimulated genes (IySGs) expression. It also suggests that MYC activation downregulates JAK2 and impairs IySGs stimulation, potentially predicting response to anti-programmed death-1/ligand-1 (PD1/L1) therapies.

CELL REPORTS MEDICINE (2023)

Review Oncology

Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics

Maxime Janin, Veronica Davalos, Manel Esteller

Summary: Most cancer-related deaths and illnesses can be attributed to metastasis. The role of epigenetic and epitranscriptomic changes in the origin and progression of cancer has been extensively demonstrated. These two-layer regulatory mechanisms, driven by DNA or RNA modifiers, are finely controlled in normal tissue but dysregulated in cancer. Understanding these mechanisms could have important clinical implications for prevention and management of advanced malignancies. Reversing these epi-alterations with small molecules or inhibitors against epi-modifiers could offer novel therapeutic alternatives.

CANCER AND METASTASIS REVIEWS (2023)

Article Biochemistry & Molecular Biology

Functional Profiling of Soft Tissue Sarcoma Using Mechanistic Models

Miriam Paya-Milans, Maria Pena-Chilet, Carlos Loucera, Marina Esteban-Medina, Joaquin Dopazo

Summary: Soft tissue sarcoma is a group of rare and difficult-to-treat cancers, and the study shows that computational analysis of gene expression data can reveal the importance of signaling pathways in patient survival. Thirteen signaling circuits were identified as predictors of patient survival, and the protective role of the immune system in the tumor microenvironment and potential therapeutic strategies were also described.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Letter Oncology

Response to Kang et al.

Carlos A. Garcia-Prieto, Veronica Davalos, Manel Esteller

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome

Lucia Salz, Alexander Seitz, Daniel Schaefer, Julia Franzen, Tatjana Holzer, Carlos A. Garcia-Prieto, Iris Buerger, Olaf Hardt, Manel Esteller, Wolfgang Wagner

Summary: CAR T cell expansion during culture leads to DNA hypermethylation, which downregulates the expression of genes relevant to T cell function. This hypermethylation signature can predict cell culture time and is associated with reduced long-term survival and therapeutic outcome in CAR T cell products.

LEUKEMIA (2023)

Article Biochemistry & Molecular Biology

Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of Andalusia

Javier Perez-Florido, Carlos S. Casimiro-Soriguer, Francisco Ortuno, Jose L. Fernandez-Rueda, Andrea Aguado, Maria Lara, Cristina Riazzo, Manuel A. Rodriguez-Iglesias, Pedro Camacho-Martinez, Laura Merino-Diaz, Inmaculada Pupo-Ledo, Adolfo de Salazar, Laura Vinuela, Ana Fuentes, Natalia Chueca, Federico Garcia, Joaquin A. Dopazo, Jose Lepe

Summary: Recombination is an evolutionary strategy to acquire new viral properties quickly. The Andalusian genomic surveillance strategy has revealed a high number of co-infections, providing an ideal setting for the emergence of new recombinants. Whole genome sequencing of SARS-CoV-2 has been conducted, detecting three novel recombinant variants with two break points. The increased frequency of co-infection and recombination raises the risk of recombinant variants with increased transmissibility and pathogenicity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

暂无数据